semaglutide neurological side effects GLP-1 meds like (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have been game-changers for diabetes and weight loss — but a new study found they may also slightly increase the risk of developing vestibular 7 Risks of Semaglutide Side

Persistent fatigue beyond 16 weeks, despite adequate nutrition and hydration, points to potential complications like thyroid disease, anemia, or vitamin B12 deficiency

Instead of giving up altogether, Schumer pivoted to Mounjaro, another GLP-1 drug, with dramatically different results

Key clinical findings for 2.4mg dose: Around 85% of people lost more than 5% of their body weight 66% of people lost more than 10% of their body weight 48% of people lost more than 15% of their body weight 30% of people lost more than 20% of their body weight These results show that Wegovy doesn't just support short-term changes, it can play a major role in achieving long-term, sustainable weight loss when used consistently and correctly

Baekdal TA, Thomsen M, Kupova V, Hansen CW, Anderson TW

At this concentration, a 100mcg target dose corresponds to 0.1mL which on a standard 1mL insulin syringe marked in 100 units equals 10 units